| Product Code: ETC5300959 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Pharmaceuticals Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Pharmaceuticals Market - Industry Life Cycle |
3.4 Taiwan Pharmaceuticals Market - Porter's Five Forces |
3.5 Taiwan Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Taiwan Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Taiwan Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Taiwan Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Taiwan Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for healthcare services in Taiwan |
4.2.2 Growing elderly population leading to higher healthcare needs |
4.2.3 Rising prevalence of chronic diseases driving pharmaceutical consumption |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment in Taiwan |
4.3.2 Competition from generic drug manufacturers impacting pricing and profitability |
4.3.3 Limited access to new innovative drugs due to regulatory hurdles |
5 Taiwan Pharmaceuticals Market Trends |
6 Taiwan Pharmaceuticals Market Segmentations |
6.1 Taiwan Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.3 Taiwan Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Taiwan Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Taiwan Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Taiwan Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Taiwan Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Taiwan Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Taiwan Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Taiwan Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Taiwan Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Taiwan Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Taiwan Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Taiwan Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Taiwan Pharmaceuticals Market Export to Major Countries |
7.2 Taiwan Pharmaceuticals Market Imports from Major Countries |
8 Taiwan Pharmaceuticals Market Key Performance Indicators |
8.1 Research and development (RD) investment in pharmaceutical sector |
8.2 Healthcare expenditure per capita in Taiwan |
8.3 Number of patents filed for new pharmaceutical products in Taiwan |
9 Taiwan Pharmaceuticals Market - Opportunity Assessment |
9.1 Taiwan Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Taiwan Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Taiwan Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Taiwan Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Taiwan Pharmaceuticals Market - Competitive Landscape |
10.1 Taiwan Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here